Clinical Reviews & Cases

Clinical Reviews & Cases

Open Access
ISSN: 2689-1069

Archive – 2022 | Volume 4 | Issue 2

Review Article DOI: 10.33425/2689-1069.1036
SARS-COV-2: the COVID-19 Virus Overcomes the Immune Response in the ‘at-risk’ group and thereby Infects the Patient yet it is the Autonomic Response which is Most Significant and Determines the Extent and Severity of Infection

Authors: Graham Wilfred Ewing.

Research Article DOI: 10.33425/2689-1069.1037
Modulation of the Innate and the Adaptive Immune Expression of THP1 Cell Line Following Infection with Leishmania L. Major and L. Donovani Isolates from Sudanese Patients

Authors: Amal F. Al Dawi, Sababil S Ali, Dalia. M. Ahmed, Maowia M. Mukhtar.

Editor-in-Chief
Roy G. Beran
Roy G. Beran
Department of Medicine | University of New South Wales

View full editorial board →
Journal Metrics
Impact Factor 2.6*
Acceptance Rate 78%
Time to first decision 6-10 Days
Submission to acceptance 12-15 Days